What is the risk of synthetic cannabis?

In France, the sale of synthetic cannabis was recently banned. DP MP Gilles Baum asked the Minister of Health whether Luxembourg will also ban synthetic cannabis, how the risk to public health is assessed and whether the population should be made aware of synthetic cannabis and its risks.

Question

« Une loi interdisant la vente et la consommation de cannabinoïdes de synthèse est entrée en vigueur hier en France. Des médecins ont soutenu que la substance hexahydrocannabinol (HHC), qui est structurellement similaire au cannabinoïde naturel THC, doit être interdite en raison de ses effets psychoactifs. Selon mes informations, il est actuellement encore possible d’acheter et de consommer des produits contenant du HHC au Luxembourg.

Dans ce contexte, j’aimerais poser les questions suivantes à Madame la Ministre de la Santé :

  • Quelle est l’évaluation de votre ministère quant aux effets psychoactifs du HHC et à leur impact sur la santé publique ?
  • Madame la Ministre, avez-vous l’intention de suivre l’exemple français et d’interdire la vente du cannabinoïde de synthèse HHC?
  • Quelles initiatives le ministère de la santé envisage-t-il pour sensibiliser le public aux risques potentiels pour la santé liés à la consommation de produits contenant du HHC au Luxembourg, et comment les professionnels de la santé seront-ils soutenus ?
  • Comment le ministère de la santé prévoit-il de surveiller l’évolution de la situation liée aux cannabinoïdes de synthèse au Luxembourg et d’évaluer l’efficacité des mesures prises pour protéger la santé publique ?
  • Quel est l’état actuel de la recherche scientifique sur le HHC et les cannabinoïdes de synthèse, et comment ces données seront-elles prises en compte dans l’élaboration des politiques de réglementation ? »

Would you like this parliamentary question to be translated into English?

Share:

Facebook
Twitter
LinkedIn
Email
WhatsApp

More parliamentary questions

No access to biological results in the LëtzHBM study?

As part of the LNS study ‘LëtzHBM’, biological and environmental samples are collected to determine the presence of chemical substances in private households. The results of the biological samples, unlike the environmental samples, are not systematically communicated to the participants.
DP MP Dr Gérard Schockmel has asked the Minister of Health why these results are not communicated and whether this is compatible with data protection regulations.

read more...

How long are the waiting times at the “Travel Clinic”?

If you are travelling to tropical regions, you can get advice and be vaccinated against various diseases at the CHL’s “Travel Clinic”. However, the waiting times at this clinic are currently said to be quite long.
DP MPs Dr Gérard Schockmel and Gilles Baum have asked the Minister of Health how many patients have been seen at the “Travel Clinic” over the last ten years, how waiting times have developed over this period and whether it would not make sense to make it possible to book appointments online, as is the case with many other CHL services.

read more...

How can the nursing assistant profession be upgraded?

The shortage of nursing staff is one of the biggest challenges facing the current government. In this context, DP MPs André Bauler and Gilles Baum wanted to know from the Minister of Health, among other things, how many nursing assistants are currently working in the country, how many have changed careers in recent years and what measures the government intends to take to make the profession more attractive again.

read more...